Simple finger-prick blood samples that can be collected at home and mailed to laboratories without refrigeration or prior processing can help detect Alzheimer's disease biomarkers accurately, according to an international study.

The research, published in the journal Nature Medicine, represents the first large-scale validation of the accessible testing approach that removes geographic barriers and opens brain disease research to global populations without requiring specialised health care infrastructure.